MAIMONE, SERGIO
 Distribuzione geografica
Continente #
NA - Nord America 1.222
EU - Europa 999
AS - Asia 236
OC - Oceania 2
SA - Sud America 2
Totale 2.461
Nazione #
US - Stati Uniti d'America 1.220
IE - Irlanda 345
SE - Svezia 293
CN - Cina 214
IT - Italia 163
PL - Polonia 52
UA - Ucraina 39
DE - Germania 38
FI - Finlandia 24
GB - Regno Unito 16
IN - India 16
BE - Belgio 12
FR - Francia 10
VN - Vietnam 5
RU - Federazione Russa 4
CA - Canada 2
NZ - Nuova Zelanda 2
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
LV - Lettonia 1
NL - Olanda 1
NO - Norvegia 1
Totale 2.461
Città #
Dublin 345
Ashburn 264
Chandler 225
Nyköping 171
Jacksonville 97
Beijing 75
Ann Arbor 54
Warsaw 52
Messina 50
Dearborn 48
Princeton 46
Medford 45
Des Moines 37
Cambridge 36
Rome 28
Jinan 20
Nanjing 20
San Mateo 17
New York 16
Shenyang 15
Pune 14
Woodbridge 14
Boardman 12
Brussels 12
Ningbo 11
Wilmington 11
Haikou 10
Avola 9
Bremen 9
Hebei 9
Houston 8
Seattle 8
Tianjin 8
Guangzhou 7
Zhengzhou 7
Catania 6
Dong Ket 4
Nanchang 4
Taizhou 4
Vittoria 4
Washington 4
Hangzhou 3
Jiaxing 3
Milan 3
Rosolini 3
Auburn Hills 2
Changsha 2
Chengdu 2
Dalmine 2
Falls Church 2
Frontone 2
Kunming 2
Lancaster 2
Manchester 2
Palermo 2
Qingdao 2
Redwood City 2
Saint Paul 2
San Severo 2
Taiyuan 2
Wellington 2
Albino 1
Alcamo 1
Augusta 1
Brescia 1
Carini 1
Caserta 1
Cormeilles-en-Parisis 1
Dipignano 1
Floridia 1
Fuzhou 1
Hanoi 1
Jeffries 1
La Canada Flintridge 1
Lanzhou 1
Lappeenranta 1
Leawood 1
Livorno 1
Los Angeles 1
Milazzo 1
Modena 1
Moscow 1
Mountain View 1
Niscemi 1
Oslo 1
Ottawa 1
Phoenix 1
Puxian 1
Ragusa 1
Sortino 1
São Paulo 1
Tappahannock 1
Torino 1
Toronto 1
Yicheng 1
Totale 1.914
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 268
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 101
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 101
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 94
Valutazione elastografica (fibroscan) del fegato nelle pazienti con sindrome di Turner 93
Atrial fibrillation in patients with cirrhosis 92
Dual-source dual-energy CT in the evaluation of hepatic fractional extracellular space in cirrhosis 89
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 68
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 66
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 63
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 63
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 63
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 60
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 58
Response to the high diagnostic characteristics of HBsAg level in differentiation of Hepatitis B clinical presentations: myth or truth? 58
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 58
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 57
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 57
Evaluation of liver stiffness using transient elastography (fibroscan) in young adults with Turner syndrome. 56
Fibroscan: a new non invasive method for cross-sectional and longitudinal evaluation of liver dysfunction in Turner syndrome 54
Assessment of liver stifness values in subjects affected by familial combined hyperlipidemia with different degree of hepatic steatosis 53
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 51
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 46
PRE-S GENETIC VARIANTS ARE HIGHLY PREVALENT AND SIGNIFICANTLY CORRELATE WITH LOWER LEVELS OF HBSAG IN ACTIVE HBV INFECTIONS 45
INFECTION WITH HBV PRES/S VARIANTS IS HIGHLY PREVALENT AND INFLUENCES AMOUNT OF CIRCULATING HBSAG INDEPENDENTLY OF SERUM HBV DNA LEVELS AND RESPONSE TO INTERFERON THERAPY IN CHRONIC HEPATITIS B 44
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 42
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 41
Does HCV antiviral therapy decrease the risk of hepatocellular carcinoma? 40
Coagulation and fibrosis in chronic liver disease 38
Erectile dysfunction in compensated liver cirrhosis 38
Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient 36
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 35
Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis 34
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 34
null 31
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 31
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 29
Impact of tips preliver transplantation for the outcome posttransplantation 28
Dual-energy CT quantification of fractional extracellular space in cirrhotic patients: comparison between early and delayed equilibrium phases and correlation with oesophageal varices 28
The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis 27
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 26
Therapy of occult hepatitis B virus infection and prevention of reactivation. 22
Models for non-alcoholic fatty liver disease: A link with vascular risk 22
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 22
null 22
Fibrosis staging in chronic hepatitis C: Analysis of discordance between transient elastography and liver biopsy 20
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis 18
null 15
Response to: A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial] 12
Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection 5
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 1
Totale 2.555
Categoria #
all - tutte 8.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 1 0 4
2019/2020275 23 10 2 5 6 50 27 22 11 68 41 10
2020/2021362 23 9 102 18 39 20 15 31 46 29 15 15
2021/2022351 5 42 12 21 21 2 18 10 2 68 46 104
2022/2023945 71 102 39 60 64 87 19 50 413 4 22 14
2023/2024393 19 33 11 21 20 62 1 222 2 2 0 0
Totale 2.555